Predicting diabetes: Our relentless quest for genomic nuggets

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 193-195

  Dagogo Jack, Samuel ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; GENOMICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PREDICTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859032367     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2106     Document Type: Note

References (25)

1. Centers for Disease Control and Prevention. Number of Americans with diabetes rises to nearly 26 million. More than a third of adults estimated to have prediabetes [press release], 2011. Available from http://www.cdc.gov/media/ releases/ 2011/p0126-diabetes.html. Accessed 20 October 2011
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
3. Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc 2003;95:774-789, 779-789
4. Egede LE, Dagogo-Jack S. Epidemiology of type 2diabetes: focus on ethnic minorities. Med Clin North Am 2005;89:949-975, viii (Pubitemid 41208274)
5. Xiang AH, Li BH, Black MH, et al. Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus. Diabetologia 2011;54:3016-3021
6. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403 (Pubitemid 34437694)
7. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350 (Pubitemid 32378388)
8. Tanizawa Y, Riggs AC, Dagogo-Jack S, et al. Isolation of the human LIM/homeodomain gene islet-1 and identification of a simple sequence repeat polymorphism[corrected]. Diabetes 1994;43:935-941 (Pubitemid 24196428)
9. Ehm MG, Karnoub MC, Sakul H, et al.; American Diabetes Association GENNID Study Group. Genetics of NIDDM. Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 2000;66:1871-1881 (Pubitemid 30480094)
10. McCarthy MI, Zeggini E. Genome-wide association studies in type 2 diabetes. Curr Diab Rep 2009;9:164-171
11. Dupuis J, Langenberg C, Prokopenko I, et al.; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-116
12. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589
13. Weedon MN, McCarthy MI, Hitman G, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 2006;3:e374
14. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008;359:2208-2219
15. Hivert MF, Jablonski KA, Perreault L, et al.; DIAGRAM Consortium; Diabetes Prevention ProgramResearch Group. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 2011;60:1340-1348
16. van Hoek M, Dehghan A, Witteman JC, et al. Predicting type 2diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 2008;57:3122-3128
17. Cooke JN, Ng MCY, Palmer ND, et al. Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care 2012;35:287-292
18. Lewis JP, Palmer ND, Hicks PJ, et al. Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from wholegenome association studies. Diabetes 2008; 57:2220-2225
19. Palmer ND, Hester JM, An SS, et al. Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 2011;60:662-668
20. McCaffery JM, Jablonski KA, Franks PW, et al.; Diabetes Prevention Program Research Group. TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. PLoS ONE 2011;6: e21518 [Epub Jul 26, 2011]
21. Fisher E, Boeing H, Fritsche A, Doering F, Joost HG, Schulze MB. Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr 2009;101:478-481
22. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K. Transcription factor 7-like 2regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008;57:645-653
23. Kirchhoff K, Machicao F, Haupt A, et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008;51:597-601
24. Florez JC, Jablonski KA, Bayley N, et al.; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355: 241-250 (Pubitemid 44079339)
25. Dagogo-Jack S, Edeoga C, Nyenwe E, Chapp-Jumbo E, Wan J. Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC): design and methods. Ethn Dis 2011;21: 33-39